|
| |
Articles
1-108 out of 108 article(s)
| Title |
Author |
Type |
Date |
Words |
| Comparative pharmacokinetics of enrofloxacin, danofloxacin, and marbofloxacin after intravenous and oral administration in Japanese quail (Coturnix coturnix japonica). |
Haritova, Aneliya; Dimitrova, Dimitrichka; Dinev, Toncho; Moutafchieva, Rumyana; Lashev, Lubomir |
|
Mar 1, 2013 |
5860 |
| Aradigm Announces Private Placement for $6 Million. |
|
|
Dec 12, 2012 |
815 |
| UK Scientists Report on Efficacy of Aradigm's Lipoquin[TM] Against Pneumonic Plague. |
|
|
Nov 19, 2012 |
1153 |
| Virginia Commonwealth University Scientists Report Anti-Inflammatory Effect of Aradigm's Inhaled Liposomal Ciprofloxacin. |
|
|
Oct 16, 2012 |
934 |
| Common antibiotic boosts spread of deadly superbug. |
|
|
Sep 21, 2012 |
386 |
| UK Scientists Report Successful Testing of Aradigm's Inhaled Liposomal Ciprofloxacin in Q Fever. |
|
|
Sep 20, 2012 |
887 |
| New U.S. Composition of Matter Patent for Aradigm's Pulmaquin[TM] and Lipoquin[TM] Provides Protection Until 2031. |
|
|
Sep 18, 2012 |
797 |
| Factors related to increasing prevalence of resistance to ciprofloxacin and other antimicrobial drugs in Neisseria gonorrhoeae, United States. |
Goldstein, Edward; Kirkcaldy, Robert D.; Reshef, David; Berman, Stuart; Weinstock, Hillard; Sabeti, |
|
Aug 1, 2012 |
5452 |
| Antibacterial activity of Thymus maroccanus and Thymus broussonetii essential oils against nosocomial infection bacteria and their synergistic potential with antibiotics. |
Fadli, Mariam; Saad, Asmaa; Sayadi, Sami; Chevalier, Jacqueline; Mezrioui, Nour-Eddine; Pages, Jean- |
Report |
May 1, 2012 |
7123 |
| Aradigm Receives U.S. FDA Clearance for Phase 3 Clinical Trial of Pulmaquin[TM] in Patients with Non-Cystic Fibrosis Bronchiectasis. |
|
|
Mar 12, 2012 |
726 |
| Is there an ototoxicity risk from cortisporin and comparable otic suspensions? Distortion-product otoacoustic emission findings. |
Berenholz, Leonard P.; Rossi, Dyana L.; Lippy, William H.; Burkey, John M. |
Report |
Mar 1, 2012 |
3277 |
| Synergistic activity of coriander oil and conventional antibiotics against acinetobacter baumannii. |
Duarte, A; Ferreira, S.; Silva, F.; Domingues, F.C. |
Report |
Mar 1, 2012 |
2157 |
| US Patent Protection for Pulmaquin[TM] Is Extended with Issuance of a Composition of Matter Patent. |
|
|
Feb 21, 2012 |
831 |
| Aradigm Selects Pulmaquin[TM] for Phase 3 Development and Announces Issuance of Its First U.S. Patent Covering Inhaled Ciprofloxacin Formulations. |
|
|
Dec 7, 2011 |
847 |
| Meningococcal infections in hospitalised patients in Pretoria. |
Moodley, T.; Lekalakala, M.R.; de Gouveia, L.; Dangor, Y.; Hoosen, A.A. |
Report |
Oct 1, 2011 |
1286 |
| Bacteremia and antimicrobial drug resistance over time, Ghana. |
Gross, Uwe; Amuzu, Sylvarius K.; de Ciman, Ring; Kassimova, Iparkhan; Gross, Lisa; Rabsch, Wolfgang; |
|
Oct 1, 2011 |
2501 |
| Aradigm Presents Additional Analyses of the Clinical Results From ORBIT-1 and ORBIT-2 Trials of Inhaled Ciprofloxacin at the 2011 European Respiratory Society (ERS) Annual Congress. |
|
|
Sep 21, 2011 |
799 |
| Aradigm Announces Private Placement for $4.75 Million. |
|
|
Jul 6, 2011 |
965 |
| Ciprofloxacin in critically ill children. |
Sideri, G.; Kafetzis, D.A.; Vouloumanou, E.K.; Papadatos, J.H.; Papadimitriou, M.; Falagas, M.E. |
Clinical report |
Jul 1, 2011 |
2720 |
| Assessing the role of proper administration of antibiotics in the treatment of corneal ulcers in dog. |
Asghari, Ahmad; Gharachorlou, Aliasghar |
Report |
Jul 1, 2011 |
1421 |
| Aradigm Reports Successful ORBIT-1 Bronchiectasis Study with Inhaled Liposomal Ciprofloxacin. |
|
|
Jun 16, 2011 |
1239 |
| Aradigm Receives FDA Orphan Drug Designation for Ciprofloxacin for Inhalation in Bronchiectasis. |
|
|
Jun 6, 2011 |
864 |
| Methicillin-resistant Staphylococcus aureus, Samoa, 2007-2008. |
Alesana-Slater, James; Ritchie, Stephen R.; Heffernan, Helen; Camp, Tracy; Richardson, Alice; Herbis |
|
Jun 1, 2011 |
5371 |
| Increasing ceftriaxone resistance in Salmonellae, Taiwan. |
Su, Lin-Hui; Teng, Wen-Shin; Chen, Chyi-Liang; Lee, Hao-Yuan; Li, Hsin-Chieh; Wu, Tsu-Lan; Chiu, Che |
|
Jun 1, 2011 |
3094 |
| Salmonella enterica serotype Typhi with nonclassical quinolone resistance phenotype. |
Accou-Demartin, Marie; Gaborieau, Valerie; Song, Yajun; Roumagnac, Philippe; Marchou, Bruno; Achtman |
|
Jun 1, 2011 |
2646 |
| Ciprofloxacin-resistant Salmonella enterica serotype Typhi, United States, 1999-2008. |
Medalla, Felicita; Sjolund-Karlsson, Maria; Shin, Sanghyuk; Harvey, Emily; Joyce, Kevin; Theobald, L |
Report |
Jun 1, 2011 |
3412 |
| Emergence of tigecycline & colistin resistant Acinetobacter baumanii in patients with complicated urinary tract infections in north India. |
Taneja, Neelam; Singh, Gagandeep; Singh, Meenakshi; Sharma, Meera |
Report |
Jun 1, 2011 |
2286 |
| Malignant otitis externa with skull base osteomyelitis. |
|
Case study |
May 14, 2011 |
1239 |
| Tools for tracking antibiotic resistance. |
|
Report |
May 1, 2011 |
4311 |
| Occurrence & antibiogram of Salmonella Typhi & S. Paratyphi A isolated from Rourkela, Orissa. |
Bhattacharya, S.S.; Das, Usha; Choudhury, B.K. |
Clinical report |
Apr 1, 2011 |
1620 |
| Rapid situation & response assessment of diarrhoea outbreak in a coastal district following tropical cyclone AILA in India. |
Panda, Samiran; Pati, Kamala Kanta; Bhattacharya, Mihir Kumar; Koley, Hemanta; Pahari, Sobha; Nair, |
Report |
Apr 1, 2011 |
3789 |
| Aradigm Completes Enrollment in Phase 2b Study of Inhaled Ciprofloxacin for the Management of Respiratory Infections in Bronchiectasis. |
|
|
Mar 22, 2011 |
1005 |
| Aradigm to Report Expanded Results from Successful Six-Month Phase 2b Bronchiectasis Study at Biotech Showcase 2011. |
|
|
Jan 6, 2011 |
1088 |
| Foreign travel and decreased ciprofloxacin susceptibility in Salmonella enterica infections. |
Al-Mashhadani, Manar; Hewson, Robert; Vivancos, Roberto; Keenan, Alex; Beeching, Nick J.; Wain, John |
|
Jan 1, 2011 |
2188 |
| Aradigm Awarded Three Therapeutic Discovery Tax Credit Grants Totaling Over $733,000 for Inhaled Liposomal Ciprofloxacin Program. |
|
|
Nov 2, 2010 |
937 |
| Plasmid-mediated quinolone resistance among non-Typhi Salmonella enterica Isolates, USA. |
Sjolund-Karlsson, Maria; Howie, Rebecca; Rickert, Regan; Krueger, Amy; Tran, Thu-Thuy; Zhao, Shaohua |
|
Nov 1, 2010 |
2106 |
| Vibrio cholerae 01 variant with reduced susceptibility to ciprofloxacin, Western Africa. |
Quilici, Marie-Laure; Massenet, Denis; Gake, Bouba; Bwalki, Barem; Olson, David M. |
Letter to the editor |
Nov 1, 2010 |
1151 |
| Aradigm Reports Successful Phase 2b Bronchiectasis Study with Inhaled Liposomal Ciprofloxacin. |
|
|
Oct 20, 2010 |
1370 |
| Aradigm Presents Results Supporting Once-Daily Dosing With Its Inhaled Liposomal Ciprofloxacin Formulations at the 2010 European Respiratory Society (ERS) Annual Congress. |
|
|
Sep 17, 2010 |
772 |
| Tumour necrosis factor neutralization in MS: a cautionary tale. |
Arnason, B.G.W. |
Clinical report |
Jul 1, 2010 |
4177 |
| Aradigm Announces Private Placement for $5 Million. |
|
|
Jun 21, 2010 |
999 |
| Aradigm Presents at the 2010 International Conference of the American Thoracic Society. |
|
Conference news |
May 17, 2010 |
665 |
| Aradigm Receives FDA Clearance for Clinical Trial of Inhaled Liposomal Ciprofloxacin in Pediatric Patients With Cystic Fibrosis. |
|
|
May 5, 2010 |
903 |
| Aradigm Completes Enrollment and Doses Last Patient in Long Term Phase 2 Study of a Novel Inhaled Ciprofloxacin Formulation for the Management of Respiratory Infections in Bronchiectasis. |
|
|
Mar 25, 2010 |
735 |
| Aradigm Doses First Patient in Its Second Phase 2b Clinical Trial of Inhaled Liposomal Ciprofloxacin in Bronchiectasis Patients. |
|
|
Feb 23, 2010 |
842 |
| Marked susceptibility of South African Helicobacter pylori strains to ciprofloxacin and amoxicillin: clinical implications. |
Tanih, Nicoline F.; Okeleye, Benjamin I.; Naidoo, Nathan; Clarke, Anna M.; Mkwetshana, Noxolo; Green |
Report |
Jan 1, 2010 |
2755 |
| Necrotizing otitis externa: a new trend? Report of 6 atypical cases. |
Glynn, Fergal; Walsh, Rory McConn |
Case study |
Dec 1, 2009 |
2029 |
| Aradigm Doses First Patient in Long-Term Phase 2 Study of a Novel Inhaled Ciprofloxacin Formulation for the Management of Respiratory Infections in Bronchiectasis. |
|
|
Nov 16, 2009 |
696 |
| Imported ciprofloxacin-resistant Neisseria meningitidis. |
Lapadula, Giuseppe; Vigano, Franco; Fortuna, Paolo; Dolara, Alberto; Bramati, Simone; Soria, Alessan |
Report |
Nov 1, 2009 |
1156 |
| Aradigm Presents Data Demonstrating Significant Antibacterial Concentrations and Effects in Non-Cystic Fibrosis Bronchiectasis Patients Following Administration of its Once-Daily Inhaled Liposomal Ciprofloxacin. |
|
|
Sep 14, 2009 |
528 |
| Ciprofloxacin: a novel therapeutic agent for iron overload?/ Siprofloksasin: demir yuklenmesi icin yeni bir terapotik ajan mi? |
Elmi, Mitra; Rahimi-Moghaddam, Parvaneh; Abdi, Khosrou; Shafiee-Ardestani, Mehdi; Mahmoudian, Massou |
Clinical report |
Sep 1, 2009 |
2119 |
| Aradigm Receives Orphan Drug Designation for Inhaled Liposomal Ciprofloxacin to Treat Cystic Fibrosis in Europe. |
|
|
Aug 5, 2009 |
576 |
| Aradigm Receives FDA Clearance for Phase IIb Clinical Trial of Inhaled Liposomal Ciprofloxacin to Treat Bronchiectasis. |
|
|
Jul 23, 2009 |
782 |
| Laboratorios SALVAT, S.A. and WraSer Pharmaceuticals, LLC Announce Exclusive License Agreement for the Commercialization of CETRAXAL[R] (ciprofloxacin otic solution) 0.2%. |
|
|
Jul 8, 2009 |
456 |
| Aradigm Presents Phase 1 and Phase 2 Data on Inhaled Liposomal Ciprofloxacin in Healthy Volunteers and Cystic Fibrosis Patients at the 32nd European Cystic Fibrosis Conference. |
|
Conference news |
Jun 11, 2009 |
521 |
| Changes in fluoroquinolone-resistant Streptococcus pneumoniae after 7-valent conjugate vaccination, Spain. |
de la Campa, Adela G.; Ardanuy, Carmen; Balsalobre, Luz; Perez-Trallero, Emilio; Marimon, Jose M.; F |
|
Jun 1, 2009 |
5508 |
| Aradigm Presents Phase 2 Data on Inhaled Liposomal Ciprofloxacin in Cystic Fibrosis and Non-Cystic Fibrosis Bronchiectasis at 2009 International Conference of the American Thoracic Society. |
|
Conference news |
May 14, 2009 |
628 |
| Aradigm Reports Positive Phase 2 Results with Inhaled Liposomal Ciprofloxacin Hydrochloride in Patients with Bronchiectasis. |
|
Financial report |
Jan 21, 2009 |
1062 |
| Molecular epidemiological characteristics of Shigella spp. isolated from river Narmada during 2005-2006. |
Sharma, Anjana; Singh, Susheel Kumar; Kori, Lokesh |
Report |
Jan 1, 2009 |
3937 |
| An increase in enteric fever cases due to Salmonella Paratyphi A in & around Chandigarh. |
Gupta, Varsha; Kaur, Jaspal; Chander, Jagdish |
Report |
Jan 1, 2009 |
2327 |
| Akorn, Inc. Announces FDA Approval of Ciprofloxacin HCl Ophthalmic Solution USP, 0.3%. |
|
|
Dec 12, 2008 |
545 |
| Aradigm Presents Phase 2 Data on Inhaled Liposomal Ciprofloxacin in Cystic Fibrosis at the North American Cystic Fibrosis Conference. |
|
Conference news |
Oct 23, 2008 |
640 |
| Aradigm Completes Enrollment in Phase 2 Study of Inhaled Liposomal Ciprofloxacin for Bronchiectasis. |
|
|
Oct 14, 2008 |
416 |
| Serogroup a Neisseria meningitidis with reduced susceptibility to ciprofloxacin. |
Strahilevitz, Jacob; Adler, Amos; Smollan, Gillian; Temper, Violeta; Keller, Nathan; Block, Colin |
Clinical report |
Oct 1, 2008 |
1268 |
| Ciprofloxacin resistance in Neisseria meningitidis, France. |
Skoczynska, Anna; Alonso, Jean-Michel; Taha, Muhamed-Kheir |
|
Aug 1, 2008 |
1136 |
| Depomed's ProQuin(R) XR Achieves First Marketing Authorization in Europe. |
|
|
Jul 23, 2008 |
978 |
| Aradigm Reports Successful Top-line Phase 2 Data with Inhaled Liposomal Ciprofloxacin for Cystic Fibrosis. |
|
Clinical report |
Jun 30, 2008 |
695 |
| Alternatives to ciprofloxacin use for enteric fever, United Kingdom. |
Threlfall, E. John; de Pinna, Elizabeth; Day, Martin; Lawrence, Joanne; Jones, Jane |
Letter to the editor |
May 1, 2008 |
1177 |
| Integrated food chain surveillance system for Salmonella spp. in Mexico (1). |
Zaidi, Mussaret B.; Calva, Juan Jose; Estrada-Garcia, Maria Teresa; Leon, Veronica; Vazquez, Gabriel |
|
Mar 1, 2008 |
5131 |
| Ciprofloxacin-resistant Salmonella enterica serotype Typhimurium, China. |
Shenghui, Cui; Jingyun, Li; Ziyong, Sun; Changqin, Hu; Shaohong, Jin; Yunchang, Guo; Lu, Ran; Yue, M |
|
Mar 1, 2008 |
2008 |
| Plasmid-mediated quinolone resistance in Salmonella enterica, United Kingdom. |
Hopkins, Katie L.; Day, Martin; Threlfall, E. John |
Letter to the editor |
Feb 1, 2008 |
1720 |
| Martec slapped with 483 for QC's lack of authority to investigate errors. |
|
|
Dec 1, 2007 |
991 |
| Martec nets 483 for inadequate laboratory controls. |
|
|
Dec 1, 2007 |
837 |
| Aradigm Initiates Phase 2 Study of Inhaled Liposomal Ciprofloxacin for Cystic Fibrosis. |
|
|
Nov 19, 2007 |
633 |
| Bacterial resistance to quinolone otic drops is nearly zero. |
Poole, Michael D. |
|
Nov 1, 2007 |
1299 |
| Relative value of different fluoroquinolones. |
Gall, Richard M. |
|
Nov 1, 2007 |
947 |
| Depomed and Watson Expand ProQuin(R) XR Promotion Agreement to Include Ob/Gyn Field. |
|
|
Sep 25, 2007 |
802 |
| Optimer Presents Positive Data on Two Lead Anti-Infective Drug Candidates. |
|
|
Sep 20, 2007 |
602 |
| Tizanidine contraindicated for use with Luvox, Cipro. |
Mechcatie, Elizabeth |
|
Aug 1, 2007 |
385 |
| Depomed Enters into Promotion Agreement with Watson for ProQuin(R) XR. |
|
|
Jul 23, 2007 |
790 |
| Depomed Reacquires the Rights to ProQuin(R) XR. |
|
|
Jul 5, 2007 |
661 |
| Community-acquired extended-spectrum [beta]-lactamase producers, United States. |
Paterson, David L. |
Letter to the editor |
Jul 1, 2007 |
1282 |
| Bioequivalence and pharmacokinetic study of two oral formulations of ciprofloxacin tablets in healthy male volunteers. |
Kalam Azad, Mohammad Abul; Ullah, Ashik; Mahbub, A.H.M.; Hasnat, Abul |
Clinical report |
Jun 1, 2007 |
4604 |
| Depomed Reports 2006 Year End Financial Results. |
|
Financial report |
Mar 14, 2007 |
901 |
| Aradigm Receives FDA Orphan Drug Designation for Liposomal Ciprofloxacin for Bronchiectasis. |
|
|
Jan 16, 2007 |
559 |
| FDA approves first generic ciprofloxacin injection, USP. |
|
|
Oct 1, 2006 |
216 |
| Effect of ciprofloxacin and levofloxacin on the QT interval: is this a significant "clinical" event? |
Goldner, Bruce |
|
Jan 1, 2006 |
3917 |
| Single drug dose may be better against cholera. |
|
Brief Article |
Oct 29, 2005 |
274 |
| The effect of natural sunlight on ciprofloxacin ophthalmic solution (1). |
Das, Subodh C. |
|
Oct 1, 2005 |
2533 |
| Ciprofloxacin does not exert nephrotoxicity in rats. |
Baykal, Asli; Sarigul, Figen; Suleymanlar, Gultekin; Moreira, Paula I.; Perry, George; Smith, Mark A |
|
Jul 1, 2005 |
2332 |
| Cephalosporin and ciprofloxacin resistance in Salmonella, Taiwan. |
Wu, Jiunn-Jong |
|
Jun 1, 2005 |
2809 |
| Bacterial meningitis. |
Worcester, Sharon |
Brief Article |
Mar 1, 2005 |
120 |
| Resistant campylobacter. |
Worcester, Sharon |
Brief Article |
Oct 15, 2003 |
150 |
| Fluoroquinolone resistance in Campylobacter jejuni isolates in travelers returning to Finland: association of ciprofloxacin resistance to travel destination. (Dispatches). |
Kotilainen, Pirkko |
|
Feb 1, 2003 |
2160 |
| Antibiotics and Crohn's disease. (Clinical Capsules). |
Evans, Jeff |
Brief Article |
Aug 15, 2002 |
148 |
| Trends in fluoroquinolone (ciprofloxacin) resistance in Enterobacteriaceae from bacteremias, England and Wales, 1990-1999. (Research). |
George, Robert C. |
|
May 1, 2002 |
4294 |
| The real Bayer fallout. (Market Horizons). |
Richter, Stephan |
Brief Article |
Feb 1, 2002 |
675 |
| A reminder-Cipro & Running. |
|
Brief Article |
Jan 1, 2002 |
288 |
| Internet ciprofloxacin. (Clinical Capsules). |
Worcester, Sharon |
|
Dec 15, 2001 |
172 |
| MED7 Ciprofloxacin immune hemolytic anemia. (Medicine). |
|
Brief Article |
Dec 1, 2001 |
295 |
| Reduced fluoroquinolone susceptibility in salmonella enterica serotypes in travelers returning from Southeast Asia. (Research). |
Siitonen, Anja |
Statistical Data Included |
Nov 1, 2001 |
5708 |
| Rapid emergence of ciprofloxacin-resistant enterobacteriaceae containing multiple gentamicin resistance-associated integrons in a Dutch hospital. (Research). |
Endtz, Hubert |
Statistical Data Included |
Sep 1, 2001 |
6902 |
| Decreased Susceptibility to Ciprofloxacin in Salmonella enterica serotype Typhi, United Kingdom. |
Ward, Linda R. |
|
May 1, 2001 |
2236 |
| High-Level Ciprofloxacin Resistance in Neisseria gonorrhoeae: First Report from Israel. |
Sheinberg, Bracha |
|
Jan 1, 2001 |
962 |
| Antibiotics and athletic injury--warning. |
|
Brief Article |
Feb 1, 2000 |
220 |
| Bacterial Resistance to Ciprofloxacin in Greece: Results from the National Electronic Surveillance System. |
Legakis, N.J. |
|
May 1, 1999 |
3510 |
| Determination of ciprofloxacin in plasma and urine by HPLC with ultraviolet detection. |
Kamberi, Marika; Tsutsumi, Kimiko; Kotegawa, Tsutomu; Nakamura, Koichi; Nakano, Shigeyuki |
|
Jun 1, 1998 |
2286 |
| Drug side effect of java jitters? |
Edwards, Diane D. |
|
Oct 17, 1987 |
217 |
|
